The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Abeona Therapeutics Inc’s current trading price is -1.28% away from its 52-week high, while its distance from the 52-week low is 83.84%. The stock’s price range for this period has been between $3.93 and $7.32 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.56 million for the day, a number notably higher than the average daily volume of 0.97 million over the last three months.
The stock of Abeona Therapeutics Inc (ABEO) is currently priced at $7.23. In the last session, the stock climbed significantly, topping out at $27.5 after opening at $7.23. The day’s lowest price was $11.0 before the stock closed at $6.56.
The market performance of Abeona Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $7.32 on 04/30/25, while the lowest value for the same duration was $3.93 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Abeona Therapeutics Inc (ABEO) has experienced a quarterly rise of 34.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 369.87M and boasts a workforce of 136 employees.
Abeona Therapeutics Inc: What Analysts Are Saying
As of right now, 5 analysts are rating Abeona Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.85, with a change in price of +2.08. Similarly, Abeona Therapeutics Inc recorded 1,405,773 in trading volume during the last 100 days, posting a change of +40.39%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABEO stands at 0.58. Similarly, the long-term debt-to-equity ratio is also 0.37.
ABEO Stock Stochastic Average
Abeona Therapeutics Inc’s raw stochastic average for the past 50 days is presently 97.75%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 96.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 58.83% and 45.19%, respectively.
ABEO Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 46.06% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 20.50%. Over the past 30 days, the price of ABEO has fallen by 15.50%. And in the last five days, it has surged by 15.31%.
